Yale University
New Haven, Connecticut, 06510, United States
NCT Number: NCT01808846
To explore whether obese adolescents with insulin resistance and relative low leptin levels exhibit functional alterations of the neuronal circuits involved in the regulation of energy metabolism and food seeking behaviors.
We here propose to test the hypothesis that the reward circuitry is dysregulated in obese adolescents and is related to the degree of insulin resistance and hyperinsulinemia.
Looking for future studies?
Notify Me12 year–17 year
All sexes
Observational
New Haven, Connecticut, 06510, United States
Functional Magnetic Resonance Imaging (fMRI) provides a non-invasive method to assess the functional pathways affected by nutrient ingestion and therefore can help answer important questions regarding potential differences in the response of brain regions involved in feeding.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Obese Insulin Resistant Adolescents
Obese Insulin Sensitive Adolescents
Eligibility criteria for healthy non-obese children and adolescents:
Exclusion criteria
Time frame: Baseline and 2 year follow up
fmri on 3T to measure blood flow response after ingestion of glucose drink
Time frame: Baseline and 2 year follow up
fmri on 3T to measure blood flow response after ingestion of fructose drink
Time frame: Baseline and 2 year follow up
fmri on 3T to measure blood flow response to visually presented food cues
Yale University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01809288
Behavior, Body Weight
Bethesda, Maryland, United States
View Trial DetailsNCT00340132
Body Weight, Body Weight Changes
Phoenix, Arizona, United States
View Trial DetailsNCT07701005
Body Weight, Digestive System Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03627104
Body Weight, Glucose Metabolism Disorders
Mexico City, Mexico
View Trial Details